Castle Hill Hospital

The trials here

What the 21 trials at this site are about, from their registry records.

Conditions

• COPD3 trials
• Head and neck cancer3 trials
• Coronary artery disease2 trials
• Idiopathic pulmonary fibrosis2 trials
• Liver and biliary tract cancer2 trials
• Lung cancer2 trials
• Asthma1 trial
• Bladder cancer1 trial
• Childhood cancers1 trial
• Chronic lymphocytic leukaemia1 trial
• Colorectal cancer1 trial
• Endometrial cancer1 trial
• and 5 more

Phase

• Phase 312 trials
• Phase 24 trials
• Phase 2/31 trial

Status

• Recruiting7 trials
• Active, not recruiting6 trials
• Completed6 trials
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• Hoffmann-La Roche4 trials
• Hull University Teaching Hospitals NHS Trust2 trials
• University of Birmingham2 trials
• BioNTech SE1 trial
• Cytokinetics1 trial
• and 11 more

Running trials

• Recruiting

  Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

  NCT07104565· Phase 2· Incyte Corporation· Source

• Recruiting

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

  NCT06340568· Phase 3· BioNTech SE· Source

• Recruiting

  Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  NCT06736574· Phase 3· Cytokinetics· Source

  Contact: Cytokinetics MD

• Active, not recruiting

  A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT06497556· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Personalized Medicine for Advanced Biliary Cancer Patients

  NCT05615818· Phase 3· UNICANCER· Source

  Contact: Anthony MARAVEYAS, MD

• Active, not recruiting

  A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

  NCT05878769· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT04666038· Phase 3· Loxo Oncology, Inc.· Source

• Recruiting

  Machine Learning in Quantitative Stress Echocardiography

  NCT04193475· Hull University Teaching Hospitals NHS Trust· Source

  Contact: Imran Sunderji

• Recruiting

  MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

  NCT04116502· Phase 3· University of Birmingham· Source

  Contact: Natalia Morelli

• Recruiting

  Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer

  NCT04050345· Royal Marsden NHS Foundation Trust· Source

  Contact: Rajarshi Roy (principal investigator)

• Active, not recruiting

  Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)

  NCT02215265· Phase 3· Lisette Nixon· Source

• Active, not recruiting

  CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)

  NCT04116047· Phase 3· University of Birmingham· Source

• Active, not recruiting

  Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

  NCT00268476· Phase 2/3· Medical Research Council· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Endometrial cancer1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Liver and biliary tract cancer1 recruiting
• Myeloproliferative neoplasms1 recruiting

Closed trials

• Terminated

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· Phase 2· Pliant Therapeutics, Inc.· Source

• Completed

  A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

  NCT05660850· Phase 2· Genentech, Inc.· Source

• Completed

  A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05595642· Phase 3· Hoffmann-La Roche· Source

• Completed

  Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

  NCT05185089· Phase 2· Nerre Therapeutics Ltd.· Source

• Completed

  Exploring the Immunology of Sarcoidosis

  NCT04637165· Hull University Teaching Hospitals NHS Trust· Source

• Completed

  A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

  NCT03782207· Hoffmann-La Roche· Source

• Completed

  Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry

  NCT03048825· Phase 3· Population Health Research Institute· Source